DocGo sees FY25 revenue $410M-$450M, consensus $418.63M

Full-year 2025 adjusted EBITDA margin is now expected to be approximately 5%, down from the previous estimate of 8%-10%. The revision is largely due to increased investment to support the growth of the Company’s care gap closure programs, add expanded mobile health offerings, and transitioning operations from migrant revenue to core mobile health revenue.